Literature DB >> 17360063

Manipulation of D2 receptors with quinpirole and sulpiride affects locomotor activity before spatial behavior of rats in an active place avoidance task.

Ales Stuchlik1, Lenka Rehakova, Lukas Rambousek, Jan Svoboda, Karel Vales.   

Abstract

Dopamine-mediated neurotransmission is widely studied with respect to motivation, motor activity and cognitive processes. The aim of the present study was to evaluate the role of D2 receptors in the behavior of rats in the active allothetic place avoidance (AAPA) task. D2 receptor agonist quinpirole and antagonist sulpiride were administered intraperitoneally 20min prior to behavioral testing. Administration of quinpirole led to dose-dependent increase of locomotion; the spatial efficiency was spared across the dose range studied (0.05-1.0mg/kg). In contrast, sulpiride decreased locomotor activity at a dose not influencing spatial efficiency (60mg/kg); the highest dose of sulpiride (100mg/kg) caused a deficit in both locomotor and spatial behaviors. The results suggest a relatively lesser importance of D2 receptors for spatial efficiency in the AAPA task, with a predominant influence of D2 receptor ligands on motor activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360063     DOI: 10.1016/j.neures.2007.02.006

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

1.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

2.  Differential DAergic Control of D1 and D2 Receptor Agonist Over Locomotor Activity and GABA Level in the Striatum.

Authors:  Eun-Yee Jung; Insop Shim
Journal:  Exp Neurobiol       Date:  2011-09-20       Impact factor: 3.261

3.  Effect of Motor Impairment on Analgesic Efficacy of Dopamine D2/3 Receptors in a Rat Model of Neuropathy.

Authors:  Margarida Dourado; Helder Cardoso-Cruz; Clara Monteiro; Vasco Galhardo
Journal:  J Exp Neurosci       Date:  2016-04-06

4.  Motivational assessment of mice using the touchscreen operant testing system: effects of dopaminergic drugs.

Authors:  Christopher J Heath; Timothy J Bussey; Lisa M Saksida
Journal:  Psychopharmacology (Berl)       Date:  2015-07-10       Impact factor: 4.530

5.  Silver Nanoparticles Impair Cognitive Functions and Modify the Hippocampal Level of Neurotransmitters in a Coating-Dependent Manner.

Authors:  Katarzyna Dziendzikowska; Małgorzata Węsierska; Joanna Gromadzka-Ostrowska; Jacek Wilczak; Michał Oczkowski; Sylwia Męczyńska-Wielgosz; Marcin Kruszewski
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

Review 6.  Influence of Prenatal Methamphetamine Abuse on the Brain.

Authors:  Anežka Tomášková; Romana Šlamberová; Marie Černá
Journal:  Epigenomes       Date:  2020-07-14

7.  Strategies discovery in the active allothetic place avoidance task.

Authors:  Avgoustinos Vouros; Tiago V Gehring; Bartosz Jura; Małgorzata J Węsierska; Daniel K Wójcik; Eleni Vasilaki
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

8.  Temporal and spatial strategies in an active place avoidance task on Carousel: a study of effects of stability of arena rotation speed in rats.

Authors:  Štěpán Bahník; Aleš Stuchlík
Journal:  PeerJ       Date:  2015-09-22       Impact factor: 2.984

9.  A Rat Model of Alzheimer's Disease Based on Abeta42 and Pro-oxidative Substances Exhibits Cognitive Deficit and Alterations in Glutamatergic and Cholinergic Neurotransmitter Systems.

Authors:  Tomas Petrasek; Martina Skurlova; Kristyna Maleninska; Iveta Vojtechova; Zdena Kristofikova; Hana Matuskova; Jana Sirova; Karel Vales; Daniela Ripova; Ales Stuchlik
Journal:  Front Aging Neurosci       Date:  2016-04-20       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.